Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nasdaq
Biotech
Singapore drug discovery platform heads to Nasdaq via SPAC deal
An AI-driven drug discovery platform will receive a step up onto the Nasdaq via a reverse merger with a blank check company.
James Waldron
Oct 2, 2025 9:50am
Barinthus enters reverse merger with metabolic disease biotech
Sep 30, 2025 10:39am
LB Pharmaceuticals eyes $228M in IPO cash
Sep 8, 2025 3:16pm
Heartflow pumps up IPO plans to $300M
Aug 6, 2025 11:20am
Coronary AI diagnostic developer Heartflow files $100M IPO
Jul 18, 2025 11:43am
Personalized spine surgery developer Carlsmed plots $100M+ IPO
Jul 16, 2025 11:44am
